메뉴 건너뛰기




Volumn 34, Issue 2, 2001, Pages 279-287

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma

Author keywords

Pleural mesothelioma; Prognostic factors; Treatment

Indexed keywords

CISPLATIN; DOXORUBICIN;

EID: 0034777549     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00257-4     Document Type: Article
Times cited : (111)

References (36)
  • 7
    • 0028825114 scopus 로고
    • A proposed new international TNM staging system for malignant pleural mesothelioma
    • (1995) Chest , vol.108 , pp. 1122-1128
  • 10
    • 0023840617 scopus 로고
    • Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985
    • (1988) J Clin Oncol , vol.6 , pp. 147-153
    • Antman, K.1    Shemin, R.2    Ryan, L.3
  • 23
    • 0027211732 scopus 로고
    • Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging
    • (1993) Cancer , vol.72 , pp. 394-404
    • Boutin, C.1    Rey, F.2    Gouvernet, J.3
  • 25
    • 0026707972 scopus 로고
    • Malignant mesothelioma: Prognostic factors in a prospective study of 98 patients
    • (1992) Lung Cancer , vol.8 , pp. 175-184
    • Tammilehto, L.1
  • 32
    • 0013886333 scopus 로고
    • Evaluation of survival data and two new rank order statistics arising in its consideration
    • (1966) Cancer Chemother Rep , vol.50 , pp. 163-170
    • Mantel, N.1
  • 35
    • 0030032572 scopus 로고    scopus 로고
    • Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas
    • (1996) Chest , vol.109 , pp. 109-114
    • Johansson, L.1    Lindén, C.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.